Keneth Newton Hall: Difference between revisions
| Line 97: | Line 97: | ||
* ''Optimal Cefazolin Prophylactic Dosing in Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.'' ''Obes Surg''. 2017 Mar; 27(3): 626–629. | * ''Optimal Cefazolin Prophylactic Dosing in Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.'' ''Obes Surg''. 2017 Mar; 27(3): 626–629. | ||
* ''Paraesophageal hiatal hernia Repair With Urinary bladder matrix Graft.'' ''JSLS''. 2018; 22(2): e2017.00100.<ref name="R28">[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002250/ "Hiatal Hernia Repair with UBM Graft – NCBI"]</ref><ref name="R29">[https://www.academia.edu/60009510/Paraesophageal_Hiatal_Hernia_Repair_With_Urinary_Bladder_Matrix_Graft | * ''Paraesophageal hiatal hernia Repair With Urinary bladder matrix Graft.'' ''JSLS''. 2018; 22(2): e2017.00100.<ref name="R28">[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002250/ "Hiatal Hernia Repair with UBM Graft – NCBI"]</ref><ref name="R29">[https://www.academia.edu/60009510/Paraesophageal_Hiatal_Hernia_Repair_With_Urinary_Bladder_Matrix_Graft "Hiatal Hernia Repair Study – Academia.edu"]</ref> | ||
* ''Laparoscopic Surgical Management of Symptomatic anastomotic ulcers After Gastric Bypass: A 10-Year Single-Center Experience.'' ''Adv in Laparoscopy'' 2020; 3(1): 82–86.<ref name="R30">[https://journals.lww.com/journalacs/Citation/2018/10001/Management_of_Symptomatic_Anastomotic_Ulcers_after.198.aspx "Anastomotic Ulcers After Gastric Bypass – JACS"]</ref> | * ''Laparoscopic Surgical Management of Symptomatic anastomotic ulcers After Gastric Bypass: A 10-Year Single-Center Experience.'' ''Adv in Laparoscopy'' 2020; 3(1): 82–86.<ref name="R30">[https://journals.lww.com/journalacs/Citation/2018/10001/Management_of_Symptomatic_Anastomotic_Ulcers_after.198.aspx "Anastomotic Ulcers After Gastric Bypass – JACS"]</ref> | ||